CN110237136A - 多甲氧基黄酮提取物在制备抵抗氧化应激产品中的应用 - Google Patents
多甲氧基黄酮提取物在制备抵抗氧化应激产品中的应用 Download PDFInfo
- Publication number
- CN110237136A CN110237136A CN201910625414.6A CN201910625414A CN110237136A CN 110237136 A CN110237136 A CN 110237136A CN 201910625414 A CN201910625414 A CN 201910625414A CN 110237136 A CN110237136 A CN 110237136A
- Authority
- CN
- China
- Prior art keywords
- cell
- polymethoxyflavone
- people
- mandarin orange
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229930182496 polymethoxyflavone Natural products 0.000 title claims abstract description 56
- 239000000284 extract Substances 0.000 title claims abstract description 24
- 230000036542 oxidative stress Effects 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 241001672694 Citrus reticulata Species 0.000 claims abstract description 56
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 52
- 210000004185 liver Anatomy 0.000 claims abstract description 33
- 210000002784 stomach Anatomy 0.000 claims abstract description 33
- 210000003606 umbilical vein Anatomy 0.000 claims abstract description 33
- 210000000981 epithelium Anatomy 0.000 claims abstract description 29
- 230000006378 damage Effects 0.000 claims abstract description 26
- 239000000843 powder Substances 0.000 claims abstract description 12
- 238000010828 elution Methods 0.000 claims abstract description 10
- 238000002414 normal-phase solid-phase extraction Methods 0.000 claims abstract description 10
- 201000010099 disease Diseases 0.000 claims abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 6
- 230000036541 health Effects 0.000 claims abstract description 5
- 235000013376 functional food Nutrition 0.000 claims abstract description 4
- 230000002265 prevention Effects 0.000 claims abstract description 3
- 230000000694 effects Effects 0.000 claims description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 102000016938 Catalase Human genes 0.000 claims description 13
- 108010053835 Catalase Proteins 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000000047 product Substances 0.000 claims description 12
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 108090000790 Enzymes Proteins 0.000 claims description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 239000001301 oxygen Substances 0.000 claims description 10
- 229910052760 oxygen Inorganic materials 0.000 claims description 10
- 235000013399 edible fruits Nutrition 0.000 claims description 9
- 101710157142 2-methylene-furan-3-one reductase Proteins 0.000 claims description 7
- 101710189291 Quinone oxidoreductase Proteins 0.000 claims description 7
- 102100034576 Quinone oxidoreductase Human genes 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 239000008367 deionised water Substances 0.000 claims description 6
- 229910021641 deionized water Inorganic materials 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 6
- 238000011068 loading method Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 208000027418 Wounds and injury Diseases 0.000 claims description 5
- 230000003833 cell viability Effects 0.000 claims description 5
- 235000019441 ethanol Nutrition 0.000 claims description 5
- 208000014674 injury Diseases 0.000 claims description 5
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 claims description 4
- 241000607479 Yersinia pestis Species 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 239000012071 phase Substances 0.000 claims description 3
- 230000005070 ripening Effects 0.000 claims description 3
- 238000001291 vacuum drying Methods 0.000 claims description 3
- 238000003828 vacuum filtration Methods 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims description 3
- ZAIANDVQAMEDFL-UHFFFAOYSA-N 3-methoxy-2-phenylchromen-4-one Chemical compound O1C2=CC=CC=C2C(=O)C(OC)=C1C1=CC=CC=C1 ZAIANDVQAMEDFL-UHFFFAOYSA-N 0.000 claims description 2
- 230000008859 change Effects 0.000 claims description 2
- YEHDMSUNJUONMW-UHFFFAOYSA-N methoxyflavone Natural products COC1=CC=CC=C1C1=CC(=O)C2=CC=CC=C2O1 YEHDMSUNJUONMW-UHFFFAOYSA-N 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 239000006228 supernatant Substances 0.000 claims description 2
- 102000004316 Oxidoreductases Human genes 0.000 claims 1
- 108090000854 Oxidoreductases Proteins 0.000 claims 1
- 230000003647 oxidation Effects 0.000 abstract description 5
- 238000007254 oxidation reaction Methods 0.000 abstract description 5
- 239000003223 protective agent Substances 0.000 abstract description 4
- 230000035882 stress Effects 0.000 abstract description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 28
- 238000011160 research Methods 0.000 description 9
- 239000000835 fiber Substances 0.000 description 8
- 239000001963 growth medium Substances 0.000 description 8
- 238000007689 inspection Methods 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- 101000973778 Homo sapiens NAD(P)H dehydrogenase [quinone] 1 Proteins 0.000 description 5
- 102100022365 NAD(P)H dehydrogenase [quinone] 1 Human genes 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000012679 serum free medium Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 239000012980 RPMI-1640 medium Substances 0.000 description 3
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000007405 data analysis Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000012894 fetal calf serum Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 239000003642 reactive oxygen metabolite Substances 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 241000207199 Citrus Species 0.000 description 2
- DOFJNFPSMUCECH-UHFFFAOYSA-N Demethylnobiletin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(O)C(OC)=C(OC)C(OC)=C2O1 DOFJNFPSMUCECH-UHFFFAOYSA-N 0.000 description 2
- -1 Flavone compound Chemical class 0.000 description 2
- 108010087230 Sincalide Proteins 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 238000010609 cell counting kit-8 assay Methods 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- OBIOZWXPDBWYHB-UHFFFAOYSA-N Nobiletin Natural products C1=CC(OC)=CC=C1C1=C(OC)C(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 OBIOZWXPDBWYHB-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000004900 autophagic degradation Effects 0.000 description 1
- 230000007321 biological mechanism Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- MRIAQLRQZPPODS-UHFFFAOYSA-N nobiletin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 MRIAQLRQZPPODS-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 238000012549 training Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供多甲氧基黄酮提取物在制备抵抗氧化应激产品中的应用。所述多甲氧基黄酮提取物为瓯柑果皮固相萃取后梯度洗脱粉末。瓯柑皮的多甲氧基黄酮提取物能够在人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI‑38细胞内显著增加抵御过氧化氢氧化应激损伤的能力,并使得细胞去除多甲氧基黄酮提取物后保持抵御氧化应激损伤能力。可作为功能食品、保健品或防治药物用于氧化应激损伤相关疾病的防治。
Description
技术领域
本发明属食品药品领域,涉及天然来源的瓯柑多甲氧基黄酮组分在制备氧化应激功能保护食品、保健品或防治药物中的应用,尤其涉及瓯柑多甲氧基黄酮提取物在人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞抵抗过氧化氢氧化应激时的应用。
背景技术
氧化和还原是自然界中最常见的化学反应,表现为共价电子对的电子得失或偏移。当生物体内的氧化物积累速率超过生物体还原反应和对氧化物清除速率时,将发生氧化应激损伤。已有研究表明,氧化应激损伤与多种疾病的发生发展相关,包括癌症、糖尿病、肥胖、神经系统疾病和动脉粥样硬化等。
天然产物可以帮助机体免受氧化应激损伤的危害,其中大部分为自身具有还原效应的,表现为与活性氧发生反应的“结合型”抗氧化天然活性物质,而可以增强细胞自身抗氧化能力,甚至使得细胞保持这种抵御氧化应激损伤的能力一段时间的天然活性产物,未见报道。
瓯柑(Citrus reticulata cv.Suavissima)是芸香科柑橘属的一个栽培变种,也是浙江省温州、丽水地区的传统特产,已经有两千多年的栽培历史。瓯柑在民间具有抗肿瘤、祛热生津、化痰止咳、清凉解毒等特殊食药功能,这些作用可能与瓯柑中富含多甲氧基黄酮类化合物有关。多甲氧基黄酮(Polymethoxylated Flavonoids,PMFs)是指具有4个及4个以上甲氧基取代基的黄酮类化合物,主要来源于芸香科柑橘属植物,尤其在柑橘果实的果皮中含量丰富。柑橘果实中的多甲氧基黄酮类化合物在抗肿瘤、抗炎、抗诱变和保护心血管等方面具有很好的活性,关于多甲氧基黄酮的生物活性机制研究也逐渐深入。自1934年首次分离出多甲氧基黄酮类化合物单体以来,人们对其活性进行了大量的研究。近年来研究发现,多甲氧基黄酮类化合物具有抑制癌细胞增殖、抵抗肿瘤侵袭和转移作用、促进癌细胞凋亡和自噬等生物活性。但是关于瓯柑多甲氧基黄酮组分的提高和保持细胞抵抗氧化应激损伤能力的研究,尚未见报道。
发明内容
本发明的目的是提供多甲氧基黄酮提取物在制备抵抗氧化应激产品中的应用。所述多甲氧基黄酮提取物为瓯柑果皮的固相萃取(SPE)梯度洗脱粉末。
所述多甲氧基黄酮提取物通过以下方法制备获得:
(1)瓯柑成熟果实,经过挑选果皮无机械损伤和病虫害的果实,进行果皮和果肉分离,液氮速冻后经过低温真空干燥,磨样后得到冷冻干燥粉末。称取冷冻干燥的瓯柑果实果皮粉末用95%乙醇(固液比比1:20)超声提取三次(25℃),每次45min,真空抽滤后,合并上清液,在旋转蒸发仪上蒸干至无乙醇相,溶于去离子水中,得到瓯柑果皮提取物水溶液。
(2)取瓯柑果皮提取物水溶液约5mL上样C18固相萃取柱(12cc/2g,Waters),上样后固相萃取柱先用去离子水洗脱25倍柱床体积(BV)去掉极性较高的杂质,然后用35%甲醇12BV进行洗脱去掉杂质,然后用100%甲醇3BV洗脱,洗脱流速为1mL/min,收集洗脱液约12mL,洗脱液在旋转蒸发仪上36℃蒸干得到207.2mg,即为瓯柑富含多甲氧基黄酮组分的粉末。
所述产品包括功能食品、保健品或防治药物。
所述抵抗氧化应激是指在人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞中显著保持过氧化氢氧化损伤时的细胞活力;在人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞中显著抑制过氧化氢诱导的活性氧积累;在人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞中显著持续降低过氧化氢诱导的活性氧积累;在人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞瓯柑多甲氧基黄酮组分可以显著增加过氧化氢酶(CAT)和醌氧化还原酶(NQO1)的酶活力;在人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞瓯柑多甲氧基黄酮组分可以显著持续增加过氧化氢酶(CAT)和醌氧化还原酶(NQO1)的酶活力。
本发明研究证明在人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞瓯柑多甲氧基黄酮组分可以显著保持过氧化氢氧化损伤时的细胞活力。
本发明研究证明在人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞瓯柑多甲氧基黄酮组分可以显著抑制过氧化氢诱导的活性氧积累。
本发明研究证明在人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞瓯柑多甲氧基黄酮组分可以显著持续降低过氧化氢诱导的活性氧积累。
本发明研究证明在人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞瓯柑多甲氧基黄酮组分可以显著增加过氧化氢酶(CAT)和醌氧化还原酶(NQO1)的酶活力。
本发明研究证明在人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞瓯柑多甲氧基黄酮组分可以显著持续增加过氧化氢酶(CAT)和醌氧化还原酶(NQO1)的酶活力。
本发明提供多甲氧基黄酮提取物在制备抵抗氧化应激产品中的应用。瓯柑皮的多甲氧基黄酮提取物能够在人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞内显著增加抵御过氧化氢氧化应激损伤的能力,并使得细胞去除多甲氧基黄酮提取物后保持抵御氧化应激损伤能力。可作为功能食品、保健品或防治药物用于氧化应激损伤相关疾病的防治。
附图说明
附图1-1是以人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞为模型,瓯柑多甲氧基黄酮组分(PMFs)对其在过氧化氢氧化损伤时细胞活性的影响。其中二甲基亚砜(DMSO)为阴性对照(control),N乙酰半胱甘酸(NAC)为阳性对照,瓯柑多甲氧基黄酮组分设置三个浓度梯度,分别为0.2mg/L、0.39mg/L、0.78mg/L。用SPSS软件进行差异显著性分析,进行t检验,*p<0.05,与control组比较。
附图1-2是以人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞为模型,在瓯柑多甲氧基黄酮组分(PMFs)预处理6h后去除PMFs组分,不同细胞在过氧化氢氧化损伤时细胞活性的影响。其中二甲基亚砜(DMSO)为阴性对照(control),N乙酰半胱甘酸(NAC)为阳性对照,瓯柑多甲氧基黄酮组分设置三个浓度梯度,分别为0.2mg/L、0.39mg/L、0.78mg/L。用SPSS软件进行差异显著性分析,进行t检验,*p<0.05,与control组比较。
附图2-1是以人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞为模型,瓯柑多甲氧基黄酮组分(PMFs)对其在过氧化氢氧化损伤时细胞内活性氧含量的相对影响。其中二甲基亚砜(DMSO)为阴性对照(control),未进行过氧化氢处理的细胞为空白对照(blank),瓯柑多甲氧基黄酮组分设置三个浓度梯度,分别为0.2mg/L、0.39mg/L、0.78mg/L。结果表示为处理组与空白组的相对含量,用SPSS软件进行差异显著性分析,进行t检验,*p<0.05,与control组比较。
附图2-2是以人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞为模型,在瓯柑多甲氧基黄酮组分(PMFs)预处理6h后去除PMFs组分,不同细胞在过氧化氢氧化损伤时细胞内活性氧的含量。其中二甲基亚砜(DMSO)为阴性对照(control),未进行过氧化氢处理的细胞为空白对照(blank),瓯柑多甲氧基黄酮组分设置三个浓度梯度,分别为0.2mg/L、0.39mg/L、0.78mg/L。结果表示为处理组与空白组的相对含量,用SPSS软件进行差异显著性分析,进行t检验,*p<0.05,与control组比较。
附图3-1是以人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞为模型,瓯柑多甲氧基黄酮组分(PMFs)对其过氧化氢酶酶活性的影响。其中二甲基亚砜(DMSO)为阴性对照(control),瓯柑多甲氧基黄酮组分设置三个浓度梯度,分别为0.2mg/L、0.39mg/L、0.78mg/L。结果表示为处理组与control组的相对含量,用SPSS软件进行差异显著性分析,进行t检验,*p<0.05,与control组比较。
附图3-2是以人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞为模型,瓯柑多甲氧基黄酮组分(PMFs)对其醌氧化还原酶酶活性的影响。其中二甲基亚砜(DMSO)为阴性对照(control),瓯柑多甲氧基黄酮组分设置三个浓度梯度,分别为0.2mg/L、0.39mg/L、0.78mg/L。结果表示为处理组与control组的相对含量,用SPSS软件进行差异显著性分析,进行t检验,*p<0.05,与control组比较。
具体实施方式
本发明结合附图和实施例作进一步的说明。
实施例1瓯柑多甲氧基黄酮组分的制备
瓯柑成熟果实(采自浙江省丽水市)经过挑选果皮无机械损伤和病虫害的果实,进行果皮和果肉分离,液氮速冻后经过低温真空干燥,磨样后得到冷冻干燥粉末。称取10.3g冷冻干燥的瓯柑果实果皮粉末用95%乙醇(固液比比1:20)超声提取三次(25℃),每次45min,真空抽滤后,合并上清液,在旋转蒸发仪上蒸干至无乙醇相,溶于去离子水中,得到瓯柑果皮提取物水溶液。
取瓯柑果皮提取物水溶液约5mL上样C18固相萃取柱(12cc/2g,Waters),上样后固相萃取柱先用去离子水洗脱25倍柱床体积(BV)去掉极性较高的杂质,然后用35%甲醇12BV进行洗脱去掉杂质,然后用100%甲醇3BV洗脱,洗脱流速为1mL/min,收集洗脱液约12mL,洗脱液在旋转蒸发仪上36℃蒸干得到207.2mg,即为瓯柑富含多甲氧基黄酮组分的粉末。瓯柑果皮提取物中主要含有川陈皮素、橘皮素和5-去甲川陈皮素。
实施例2瓯柑多甲氧基黄酮组分对人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞受到过氧化氢氧化应激损伤时细胞活性的影响
人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞用含10%胎牛血清的RPMI-1640培养基于37℃、5%CO2细胞培养箱中孵育,隔天更换新鲜培养液,2-3天传代1次。实验时,L02、GES、HUVEC、WI-38细胞接种于96孔板。待细胞生长至70-80%融合,弃去原培养基,分组加药。设空白对照组(无过氧化氢处理),DMSO溶剂对照组,N乙酰半胱甘酸(NAC)对照组(终浓度为2mmol/L)和不同浓度瓯柑多甲氧基黄酮组分组(终浓度分别为0.78mg/L、0.39mg/L、0.20mg/L)。作用6h后,保留(或移除)含有多甲氧基黄酮组分的培养基,加入含有浓度为0.78mmol/L过氧化氢的无血清培养基。孵育30min后,移除原培养基,使用PBS清洗两次,然后加入含有10%CCK-8试剂的无血清培养基。孵育1h后,用酶标仪检测各孔OD值(检测波长:450nm和620nm),用CCK-8法测定细胞活力,细胞活力计算方法为(试验孔OD450–试验孔OD620)/(空白对照OD450–空白对照OD620)。每组设定3个复孔,实验平行重复3次。
数据用平均值±标准误表示,使用SPSS软件进行数据分析,进行t检验。具体的瓯柑多甲氧基黄酮组分对人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞受到过氧化氢氧化应激损伤时细胞活性的影响见附图1。
实施例3瓯柑多甲氧基黄酮组分对人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞受到过氧化氢氧化应激损伤时细胞内活性氧含量的影响
人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞用含10%胎牛血清的RPMI-1640培养基于37℃、5%CO2细胞培养箱中孵育,隔天更换新鲜培养液,2-3天传代1次。实验时,L02、GES、HUVEC、WI-38细胞接种于96孔板。待细胞生长至70-80%融合,弃去原培养基,分组加药。设空白对照组(无过氧化氢处理),DMSO溶剂对照组和不同浓度瓯柑多甲氧基黄酮组分组(终浓度分别为0.78mg/L、0.39mg/L、0.20mg/L)。作用6h后,保留(或移除)含有多甲氧基黄酮组分的培养基,加入含有浓度为0.78mmol/L过氧化氢的无血清培养基。孵育30min后,移除原培养基,使用PBS清洗两次,加入含有终浓度为10μmol/L的DCFH-DA探针的无血清培养基。孵育20min后,移除原培养基,使用无血清培养基洗3次,使用酶标仪以488nm为激发波长,以525nm为检测波长,读取各孔的荧光值。每组设定3个复孔,实验平行重复3次。
数据用平均值±标准误表示,使用SPSS软件进行数据分析,进行t检验。具体的瓯柑多甲氧基黄酮组分对人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞受到过氧化氢氧化应激损伤时细胞内活性氧的影响见附图2。
实施例4瓯柑多甲氧基黄酮组分对人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞细胞内抗氧化酶活性的影响
人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞用含10%胎牛血清的RPMI-1640培养基于37℃、5%CO2细胞培养箱中孵育,隔天更换新鲜培养液,2-3天传代1次。实验时,L02、GES、HUVEC、WI-38细胞接种于96孔板。待细胞生长至70-80%融合,弃去原培养基,分组加药。设DMSO溶剂对照组和不同浓度瓯柑多甲氧基黄酮组分组(终浓度分别为0.78mg/L、0.39mg/L、0.20mg/L)。作用6h后,保留(或移除)含有多甲氧基黄酮组分的培养基。使用碧云天过氧化氢酶检测试剂盒(S0051)检测过氧化氢酶(CAT)酶活性。使用Abcam公司醌氧化还原酶检测试剂盒(ab184867)检测醌氧化还原酶(NQO1)酶活性。
数据用平均值±标准误表示,使用SPSS软件进行数据分析,进行t检验。具体的瓯柑多甲氧基黄酮组分对人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞细胞内抗氧化酶的活性影响见附图3。
Claims (8)
1.一种多甲氧基黄酮提取物在制备抵抗氧化应激产品中的应用,其特征在于,所述多甲氧基黄酮提取物为瓯柑果皮固相萃取后梯度洗脱粉末。
2.根据权利要求1所述的应用,其特征在于,所述产品包括功能食品、保健品或防治药物。
3.根据权利要求1所述的应用,其特征在于,所述抵抗氧化应激是指在人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞中显著保持过氧化氢氧化损伤时的细胞活力。
4.根据权利要求1所述的应用,其特征在于,在人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞中显著抑制过氧化氢诱导的活性氧积累。
5.根据权利要求1所述的应用,其特征在于,在人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞中显著持续降低过氧化氢诱导的活性氧积累。
6.根据权利要求1所述的应用,其特征在于,在人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞瓯柑多甲氧基黄酮组分可以显著增加过氧化氢酶和醌氧化还原酶的酶活力。
7.根据权利要求1所述的应用,其特征在于,在人肝L02细胞、人胃GES细胞、人脐静脉上皮HUVEC细胞、人成纤维WI-38细胞瓯柑多甲氧基黄酮组分可以显著持续增加过氧化氢酶和醌氧化还原酶的酶活力。
8.权利要求1所述的多甲氧基黄酮提取物的制备方法,其特征在于,通过以下步骤获得:
(1)瓯柑成熟果实,经过挑选果皮无机械损伤和病虫害的果实,进行果皮和果肉分离,液氮速冻后经过低温真空干燥,磨样后得到冷冻干燥粉末,称取冷冻干燥粉末用固液比比为1:20的95%乙醇超声提取三次,每次45min,真空抽滤,合并上清液,在旋转蒸发仪上蒸干至无乙醇相,溶于去离子水中,得到瓯柑果皮提取物水溶液;
(2)取瓯柑果皮提取物水溶液,上样C18固相萃取柱,12cc/2g,Waters,上样后固相萃取柱先用去离子水洗脱25倍柱床体积,去掉极性较高的杂质,然后用35%甲醇12柱床体积再进行洗脱去掉杂质,然后用100%甲醇3BV洗脱,洗脱流速为1mL/min,收集洗脱液,洗脱液在旋转蒸发仪上36℃蒸干得到洗脱粉末,即得瓯柑富含多甲氧基黄酮提取物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910625414.6A CN110237136A (zh) | 2019-07-11 | 2019-07-11 | 多甲氧基黄酮提取物在制备抵抗氧化应激产品中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910625414.6A CN110237136A (zh) | 2019-07-11 | 2019-07-11 | 多甲氧基黄酮提取物在制备抵抗氧化应激产品中的应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110237136A true CN110237136A (zh) | 2019-09-17 |
Family
ID=67891972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910625414.6A Pending CN110237136A (zh) | 2019-07-11 | 2019-07-11 | 多甲氧基黄酮提取物在制备抵抗氧化应激产品中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110237136A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114146124A (zh) * | 2021-11-04 | 2022-03-08 | 中山大学 | 茶枝柑胎多甲氧基黄酮类化合物在制备抗氧化剂中的应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109172667A (zh) * | 2018-10-17 | 2019-01-11 | 浙江大学 | 一种瓯柑果实富含多甲氧基黄酮组分提取物的降糖用途 |
-
2019
- 2019-07-11 CN CN201910625414.6A patent/CN110237136A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109172667A (zh) * | 2018-10-17 | 2019-01-11 | 浙江大学 | 一种瓯柑果实富含多甲氧基黄酮组分提取物的降糖用途 |
Non-Patent Citations (2)
Title |
---|
王岳: "瓯柑果实中多甲氧基黄酮的分离纯化研究", 《中国园艺学会2018年学术年会论文摘要集》 * |
钱井: "柑橘黄酮类化合物组分鉴定与抗氧化活性研究", 《中国优秀硕士学位论文全文数据库农业科技辑》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114146124A (zh) * | 2021-11-04 | 2022-03-08 | 中山大学 | 茶枝柑胎多甲氧基黄酮类化合物在制备抗氧化剂中的应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jayabalan et al. | Changes in content of organic acids and tea polyphenols during kombucha tea fermentation | |
Chen et al. | Morphological and genetic characterization of a cultivated Cordyceps sinensis fungus and its polysaccharide component possessing antioxidant property in H22 tumor-bearing mice | |
Wen et al. | Effects of fermentation treatment on antioxidant and antimicrobial activities of four common Chinese herbal medicinal residues by Aspergillus oryzae | |
TWI373307B (zh) | ||
Vamanu | Antioxidant properties of mushroom mycelia obtained by batch cultivation and tocopherol content affected by extraction procedures | |
Pothitirat et al. | Free radical scavenging and anti-acne activities of mangosteen fruit rind extracts prepared by different extraction methods | |
CN104430851B (zh) | 一种降胆固醇发酵乳及其制备方法 | |
Zhang et al. | Chemical composition and antioxidant properties of five edible Hymenomycetes mushrooms | |
CN104738256A (zh) | 茯茶及其制备方法和用途 | |
CN109112225A (zh) | 一种诺丽自然发酵过程中关键微生物甄别及筛选的方法 | |
CN109266559B (zh) | 一种哈茨木霉ltr-2的应用 | |
Sunil et al. | In vitro alpha-glucosidase inhibitory, total phenolic composition, antiradical and antioxidant potential of Heteromorpha arborescens (Spreng.) Cham. & Schltdl. leaf and bark extracts | |
CN110237136A (zh) | 多甲氧基黄酮提取物在制备抵抗氧化应激产品中的应用 | |
Bolaniran et al. | Nutritional value and safety of air potato Dioscorea bulbifera L. fermented with Pleurotus ostreatus and Calocybe indica | |
CN110433188A (zh) | 蓝花参提取物在制备治疗或预防炎症性肠病的药物中的应用 | |
CN101234951A (zh) | 联苯类化合物及其制备方法和应用 | |
CN101487022A (zh) | 抑制肝癌细胞生长的发酵液的制备方法 | |
CN103880826A (zh) | 一种异苯并呋喃酮化合物及其制备方法和应用 | |
CN109674051A (zh) | 一种乳酸菌发酵富集元麦多酚及制备抗氧化剂的方法 | |
CN110129376A (zh) | 银杏内生真菌代谢产物及在制备抗氧化剂中的应用 | |
Shehata et al. | Biotechnological Production of Kojic Acid Synthesized by Endophytic Fungi, Aspergillus oryzae Isolated from Euphorbia peplis. | |
CN109288902A (zh) | 一种具有强抗氧化活性的酸枣叶总黄酮发酵产物的制备方法及其应用 | |
CN105167061A (zh) | 一种马铃薯保健品及其制备方法和应用 | |
CN107475123B (zh) | 金线莲内生真菌及其应用 | |
CN102286565A (zh) | 一种茶黄素单体的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190917 |
|
WD01 | Invention patent application deemed withdrawn after publication |